PACB compared with A: revenue, margins and what each company keeps, and the suppliers and customers both name

PACBPacific Biosciences of California, Inc.

Mkt capRevenueRevenue

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

Compare

PACBPacific Biosciences of California, Inc.

AAgilent Technologies, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PACB 2

—Illumina Cambridgeunlistedsupplier

—Buyerunlistedcustomer

Shared 0

No shared counterparties.

Only A 2

ALNYAlnylam Pharmaceuticalscustomer

WGSGeneDxcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PACBPacific Biosciences of California, Inc.

2.27▼−6.79%· post 2.24

Mkt cap$705.6MRevenue$41MQ3 FY26Revenue$160MFY25

AAgilent Technologies, Inc.

174.77▲+1.74%· post 175.00

ClosedNov 6 '26

Mkt cap$48.4BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

Compare

ClosedNov 6 '26

PACBPacific Biosciences of California, Inc.

AAgilent Technologies, Inc.

2.27▼−6.79%post 2.24

Price

174.77▲+1.74%post 175.00

$705.6M

Mkt cap

$48.4B

Q3 FY26$41M

Revenue

$1.9BQ3 FY26

FY25$160M

Revenue

$6.9BFY25

PACB2.27▼−6.79%vsA174.77▲+1.74%ClosedNov 6 '26